Blog

Global Antibody Drug Conjugate (ADC) Market Trends and Forecasts Report 2023

DUBLIN--(BUSINESS WIRE)--Aug 28, 2023-- The "Antibody Drug Conjugate Market (7th Edition): Distribution by Target Diseas

Antibody drug conjugates

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal an

In Proof

NEW YORK – Mythic Therapeutics is advancing an antibody-drug conjugate for MET-driven cancers designed to be more tolera

Global Antibody Drug Conjugate (ADC) Growth Opportunities, Forecast to 2028

This research service overviews the global ADC market and provides a 6-year revenue forecast from 2023 to 2028. An ADC c

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies

INTRODUCTION. The ADC technology market, comprising of ADC linker and antibody conjugation technologies is expected to g

Chinese researchers patent new antibody

Chinese researchers patent new antibody-drug conjugates targeting IL-4R | BioWorld

Bio

GUANGZHOU, China, Aug. 12, 2023 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutic

Oncusp's CDH6

Oncusp's CDH6-targeting ADC CUSP-06 cleared to enter clinic for solid tumors | BioWorld

ADC Cleavable Linker: Classification and Mechanism of Action

ADC is a monoclonal antibody covalently bound to cytotoxic chemical substances (payload) through linker. ADC linker play

The ADC Technology Market is projected to grow at a CAGR of ~12% till 2035, claims Roots Analysis

News provided by 23 Aug, 2023, 10:10 ET Share this article With the rising demand for more efficient and homogenous anti

Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors

News provided by 28 Aug, 2023, 04:30 ET Share this article CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, A

How Linker Technology Is Driving ADC Development

By Tyler Menichiello, contributing editor If you’re still not excited about antibody drug conjugates (ADC), “there’s an